Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Active Pharmaceutical Ingredients (APIs). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111518229B reveals a novel method for removing elemental impurities in Sugammadex Sodium. Achieve ICH compliance and reduced manufacturing costs with scalable purification.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN103102395A reveals a hybrid solid-phase and liquid-phase oxidation method for high-purity Desmopressin Acetate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel chromatography and crystallization method ensures high-purity Ambroxol HCl. Reduces toxic solvents and enhances supply chain stability for global pharmaceutical manufacturing.
Patent CN101613312A reveals a high-yield convergent synthesis for Atorvastatin Calcium, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN115650863A reveals a 4-step route to Venlafaxine HCl with 67% yield. Ideal for cost-effective API manufacturing and scalable supply chains.
Novel mild temperature route for Anastrozole production reduces impurities and eliminates column chromatography, ensuring cost-effective supply chain stability.
Patent CN101307040B details a novel NBS addition method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in API manufacturing and high purity.
Patent CN114075258A reveals a hypochlorite-based purification and resin hydrolysis route for hydrocortisone, offering >99.5% purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN109748950B reveals a novel Pd-catalyzed solid-phase method for Selepressin, offering high purity and simplified purification for reliable pharmaceutical intermediate supply chains.
Novel DAC chromatography method ensures ICH compliant Orlistat purity with reduced solvent waste and enhanced supply chain reliability for global pharmaceutical manufacturing.
Patent CN113993851A details a novel Valsartan refining method reducing NDMA to ≤0.03ppm. Discover the cost-effective, scalable acid-base purification technology for high-purity API manufacturing.
Novel patent CN119409709A details high-yield lornoxicam preparation reducing impurities and enhancing supply chain reliability for pharmaceutical manufacturing.
Patent CN101597325B details a scalable RP-HPLC purification method for Leuprorelin, ensuring high purity and yield for pharmaceutical supply chains.
Patent CN102070693A details a high-yield chiral hydrogenation method for ursodeoxycholic acid, offering superior purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN113214267B reveals a novel one-step crystallization method for eszopiclone, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Advanced preparation method for Pitavastatin Calcium offering high yield and simplified purification for reliable API supply chains and cost-effective manufacturing.
Patent CN102816211B details a high-yield Fmoc solid-phase synthesis for Afamelanotide, offering safer production and cost reduction in pharmaceutical manufacturing.
Patent CN114195881B reveals a novel ionic liquid method for high-purity Sermorelin Acetate production, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104592337A reveals improved phosphorylation method ensuring high purity and simplified processing for cost reduction in API manufacturing supply chains.